Author: Perlstein EO

References 13 references

Download References (.nbib)

Vignogna RC, et al. (2022) Evolutionary rescue of phosphomannomutase deficiency in yeast models of human disease. Elife 11 PMID:36214454
Lao JP, et al. (2019) Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation. G3 (Bethesda) 9(2):413-423 PMID:30530630
Chen J, et al. (2012) Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy. PLoS One 7(4):e34024 PMID:22529904
Rainey MM, et al. (2010) The antidepressant sertraline targets intracellular vesiculogenic membranes in yeast. Genetics 185(4):1221-33 PMID:20457874
Chen BJ, et al. (2009) Harnessing gene expression to identify the genetic basis of drug resistance. Mol Syst Biol 5:310 PMID:19888205
Ruderfer DM, et al. (2009) Using expression and genotype to predict drug response in yeast. PLoS One 4(9):e6907 PMID:19730698
de Bivort BL, et al. (2009) Amino acid metabolic origin as an evolutionary influence on protein sequence in yeast. J Mol Evol 68(5):490-7 PMID:19357800
Perlstein EO, et al. (2007) Evolutionarily conserved optimization of amino acid biosynthesis. J Mol Evol 65(2):186-96 PMID:17684697
Perlstein EO, et al. (2007) Quantifying fitness distributions and phenotypic relationships in recombinant yeast populations. Proc Natl Acad Sci U S A 104(25):10553-8 PMID:17566105
Perlstein EO, et al. (2007) Genetic basis of individual differences in the response to small-molecule drugs in yeast. Nat Genet 39(4):496-502 PMID:17334364
Butcher RA, et al. (2006) Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat Chem Biol 2(2):103-9 PMID:16415861
Perlstein EO, et al. (2006) Revealing complex traits with small molecules and naturally recombinant yeast strains. Chem Biol 13(3):319-27 PMID:16638537
Bernstein BE, et al. (2004) Global nucleosome occupancy in yeast. Genome Biol 5(9):R62 PMID:15345046